CURE Pharmaceutical, an innovative drug delivery and development company, announced that it will participate in an educational panel about cannabis science in Hawaii. The “Dinner & Dialogue” is put on by Lua Ola, Hawaii’s leading medical cannabis provider, and will address how to build a pharmaceutical cannabis system in the state.
The panel will take place on Tuesday, March 27, in Honolulu.
CURE is leveraging the synergism created by combining cannabinoids and terpenes into its advanced oral thin film, CUREfilm™, a proprietary polymer and encapsulation platform. CURE’s CEO, Robert Davidson will participate on the panel in Hawaii and will discuss the company’s pharmaceutical cannabinoid projects.
“It is essential to share our knowledge and understanding on potential pharmaceutical cannabinoid drug formulations and delivery systems because many medical needs are not currently being met by traditional pharmaceuticals,” Davidson said. “This panel is made up of some of the leading minds in the field so we can work together to get FDA-approved drugs to market for those who need them.”